https://www.pharmaceutical-business-review.com/news/niaid-awards-sttr-grant-to-advance-tb-computational-tool-research-170812/ 2012-08-16T19:10:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-signs-distribution-agreement-with-seyer-for-soltamox-170812/ 2012-08-17T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/nectid-commences-clinical-development-of-agomelatine-in-us-170812/ 2012-08-17T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/accelr8-technology-relocates-headquarters-to-tucson-arizona-170812/ 2012-08-17T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/oncolytics-completes-enrolment-in-reolysin-combination-trial-170812/ 2012-08-17T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/biosyent-pharma-to-distribute-two-new-drug-products-in-canada-180812/ 2012-08-17T04:45:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/environmental-protection-agency-plans-to-clean-up-diaz-chemical-site-in-us-170812/ 2012-08-17T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/sfda-grants-glp-certification-to-wuxi-suzhou-toxicology-facility-170812/ 2012-08-17T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/myriad-receives-positive-gene-patent-ruling-170812/ 2012-08-17T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-announces-preliminary-results-from-phase-1-studies-of-lx2931-lx7101-170812/ 2012-08-17T07:52:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/niaid-supports-trellis-bioscience-cmv-program-170812/ 2012-08-17T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/rhizen-pharmaceuticals-tg-therapeutics-collaborate-on-pi3k-delta-inhibitor-170812/ 2012-08-17T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cz-biomed-licenses-us-patents-for-anti-cancer-treatment-170812/ 2012-08-17T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-to-build-new-building-for-investigational-drug-substance-production-200812/ 2012-08-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-anda-for-pioglitazone-tablets-200812/ 2012-08-19T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/elsevier-integrates-reaxys-with-electronic-laboratory-notebook-200812/ 2012-08-20T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/abgenomics-obtains-fda-agreement-on-abgn-168h-phase-2-clinical-trial-plans-200812/ 2012-08-20T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-introduces-generic-actoplus-met-200812/ 2012-08-20T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-unveils-generic-actos-in-us-200812/ 2012-08-20T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/tradjenta-insulin-tablets-receive-fda-approval-200812/ 2012-08-20T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/american-healthcare-to-distribute-injex-30-in-us-west-coast-states-200812/ 2012-08-20T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/oculus-initiates-microcyn-hydrogel-study-200812/ 2012-08-20T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-launches-pioglitazone-in-us-200812/ 2012-08-20T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-launches-anti-lice-lotion-in-us-240812/ 2012-08-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/church-dwight-signs-650m-acquisition-agreement-with-avid-health-240812/ 2012-08-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/perkinelmer-unveils-chembiooffice-version-130-210812/ 2012-08-20T19:55:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-unveils-generic-xopenex-inhalation-solution-210812/ 2012-08-21T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/integenx-introduces-human-dna-identification-system-in-europe-210812/ 2012-08-21T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fina-cdibp-sign-licensing-deal-for-conjugate-vaccine-technology-210812/ 2012-08-21T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/united-drug-to-buy-bilcare-gcs-business-in-uk-us-210812/ 2012-08-21T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyclics-enrols-fifth-patient-for-mantle-cell-lymphoma-clinical-trial-210812/ 2012-08-21T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/reckitt-benckiser-receives-fda-approval-for-suboxone-tablets-210812/ 2012-08-21T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-state-drug-makers-object-new-food-safety-act-210812/ 2012-08-21T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ocular-begins-pilot-phase-ii-travoprost-punctum-plug-trial-210812/ 2012-08-21T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/lifecodexx-introduces-praena-test-in-germany-austria-liechtenstein-switzerland-210812/ 2012-08-21T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/raybiotech-screening-assays-used-to-identify-chemoresistance-pathway-210812/ 2012-08-21T08:43:00+00:00 https://www.pharmaceutical-business-review.com/news/molecular-partners-allergan-expand-alliance-to-develop-darpin-products-220812/ 2012-08-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biodem-vivalis-develop-new-viral-vector-240812/ 2012-08-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bcrt-pluristem-extend-five-year-research-agreement-240812/ 2012-08-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alexza-adasuve-manufacturing-facility-wins-eu-certificate-of-gmp-compliance-220812/ 2012-08-22T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nutrigold-unveils-new-weight-management-supplement-220812/ 2012-08-22T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-warns-against-using-reumofan-dietary-supplements-220812/ 2012-08-22T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-supports-arteriocyte-stem-cell-expansion-technology-development-220812/ 2012-08-22T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-completes-evaluation-of-claris-lifesciences-ahmedabad-site-220812/ 2012-08-22T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/study-says-vitamin-d-supplements-decrease-risk-of-respiratory-infections-in-kids-220812/ 2012-08-22T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/phasebio-initiates-phase-2b-trial-of-glymera-220812/ 2012-08-22T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/zushima-analgesic-spray-receives-chinese-army-new-drug-certificate-220812/ 2012-08-22T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-wockhardt-hypertension-drug-220812/ 2012-08-22T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/geno-wins-four-additional-us-patents-for-nitric-oxide-technology-220812/ 2012-08-22T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/inspiration-ipsen-revise-2010-strategic-partnership-agreement-220812/ 2012-08-22T09:00:00+00:00 https://www.pharmaceutical-business-review.com/news/pra-expands-chinese-operations-230812/ 2012-08-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-to-review-dynax-heplisav-marketing-authorization-application-230812/ 2012-08-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/xoma-gets-orphan-drug-designation-for-modulating-antibody-230412/ 2012-08-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/west-pharmaceutical-to-build-new-compression-molding-plant-in-india-230812/ 2012-08-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-takeover-biochrom-230812/ 2012-08-23T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/proteonomix-signs-worldwide-licensing-contract-for-anti-tumor-technology-230812/ 2012-08-23T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-introduces-next-generation-sequencing-service-230812/ 2012-08-23T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/xyntek-forms-strategic-alliance-with-antares-vision-230812/ 2012-08-23T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/biota-inavir-meets-primary-endpoint-in-phase-iii-study-230812/ 2012-08-23T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/thermogenesis-completes-cryoseal-transaction-with-asahi-230812/ 2012-08-23T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/kineta-receives-netherlands-regulatory-clearance-for-shk-186-phase-1-trial-230812/ 2012-08-23T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/millennium-begins-pharmacogenetics-clinical-outcomes-study-230812/ 2012-08-23T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/wockhardt-wins-tentative-fda-approval-for-generic-geodon-230812/ 2012-08-23T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-join-forces-with-mylan-for-generic-drugs-development-230812/ 2012-08-23T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/positron-submits-dmf-of-api-grade-strontium-82-230812/ 2012-08-23T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/transgenomic-to-advance-pancreatic-cancer-research-with-nih-grant/ 2012-08-23T08:50:00+00:00 https://www.pharmaceutical-business-review.com/news/metabolon-files-lawsuit-against-stemina-biomarker-240812/ 2012-08-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/agennix-to-cut-workforce-to-conserve-cash-240812/ 2012-08-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/neutra-carries-on-male-enhancement-supplements-trials-240812/ 2012-08-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-biologics-commences-phase-3-program-of-sirukumab-240812/ 2012-08-24T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/isaec-uc-san-diego-collaborate-on-diri-genetics-research-240812/ 2012-08-24T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/synergy-takes-over-fv-100-shingles-drug-from-bristol-myers-240812/ 2012-08-24T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ehealth-awards-technology-service-contract-to-saic-240812/ 2012-08-24T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-watson-laboratories-anda-of-generic-lidoderm-240812/ 2012-08-24T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-terminates-development-of-bms-986094-240813/ 2012-08-24T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/novira-secures-23m-in-series-a-financing-to-advance-antiviral-research-240812/ 2012-08-24T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/cleanpath-launches-new-natural-herbal-supplements-240812/ 2012-08-24T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/rock-creek-enrolls-first-patient-in-anatabloc-dietary-supplement-study-240812/ 2012-08-24T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-to-resubmit-lemtrada-marketing-application-to-fda-270812/ 2012-08-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-alzheimers-drug-solanezumab-fails-to-meet-endpoints-270812/ 2012-08-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-trastuzumab-emtansine-improves-survival-rate-in-phase-iii-trial-270812/ 2012-08-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-begins-cpp-disease-study-270812/ 2012-08-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medqia-develops-new-software-toolkit-of-image-analysis-routines-270812/ 2012-08-26T20:57:00+00:00 https://www.pharmaceutical-business-review.com/news/walgreens-installs-greenway-ehr-solution-270812/ 2012-08-27T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/computer-task-group-wins-healthcare-it-contracts-270812/ 2012-08-27T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-eli-lilly-trilogy-acs-study-fails-to-meet-primary-endpoint-270812/ 2012-08-27T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/rivalus-launches-powder-burn-supplements-270812/ 2012-08-27T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-begins-phase-ib-rcc-trial-of-sgn-75-270812/ 2012-08-27T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/us-appeals-court-confirms-validity-of-eli-lilly-alimta-compound-patent-270812/ 2012-08-27T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-meda-zyclara-270812/ 2012-08-27T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/mediterranea-to-sell-diasys-ivd-equipments-270812/ 2012-08-27T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-emilia-study-of-trastuzumab-emtansine-meets-co-primary-efficacy-endpoints-270812/ 2012-08-27T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-updates-on-cardiovascular-development-programs-270812/ 2012-08-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-signs-licensing-deal-with-depomed-for-acuform-patents-280812/ 2012-08-28T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/cool-containers-to-introduce-non-dry-ice-active-container-280812/ 2012-08-28T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/rbc-life-sciences-stem-cell-supplement-wins-approval-in-taiwan-280812/ 2012-08-28T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bode-technology-launches-rapid-dna-service-280812/ 2012-08-28T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/morphotek-begins-phase-ii-metastatic-soft-tissue-sarcoma-study-280812/ 2012-08-28T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/avita-manufacturing-improvements-yield-significant-margin-expansion-280812/ 2012-08-28T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-warns-pacira-for-anti-cancer-medicine-manufacturing-280812/ 2012-08-28T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-tris-pharm-announces-launch-of-delsym-store-brand-version-280812/ 2012-08-28T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/nanoviricides-reports-positive-results-from-flucide-program-280812/ 2012-08-28T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-packaging-opens-new-packaging-facility-in-india-280812/ 2012-08-28T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/biotime-receives-expanded-license-to-hystem-technology-280812/ 2012-08-28T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-gilead-hiv-1-infection-tablet-280812/ 2012-08-28T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-introduces-new-capsule-filling-machines-280812/ 2012-08-28T08:46:00+00:00 https://www.pharmaceutical-business-review.com/news/millstone-to-expand-us-operations-290812/ 2012-08-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-novartis-myelofibrosis-therapy-290812/ 2012-08-29T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/cangene-extends-biodefence-contracts-with-us-290812/ 2012-08-29T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-dose-strength-of-exalgo-drug-280812/ 2012-08-29T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/mmv-selects-uct-developed-anti-malaria-molecule-for-clinical-trials-290812/ 2012-08-29T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-commences-phase-2a-trial-of-aezs-130-290812/ 2012-08-29T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/rockwell-gains-canadian-patent-for-iron-replacement-therapy/ 2012-08-29T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/merz-acquires-cuvposa-drug-290812/ 2012-08-29T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/usfda-clears-caraco-to-resume-operations-290812/ 2012-08-29T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/spinifex-ema401-meets-primary-endpoint-in-phase-2-trial-290812/ 2012-08-29T08:56:00+00:00 https://www.pharmaceutical-business-review.com/news/genetex-to-launch-new-hypoxia-antibody-290812/ 2012-08-29T08:59:00+00:00 https://www.pharmaceutical-business-review.com/news/canada-funds-lorus-cancer-therapy-program-300812/ 2012-08-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/spar-glaxosmithkline-sign-45m-in-store-merchandising-contract-300812/ 2012-08-30T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-selects-third-target-under-research-collaboration-with-theraclone-300812/ 2012-08-30T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/alk-signs-pre-pen-supply-contract-with-healthtrust-300812/ 2012-08-30T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-to-buy-orchid-chemicals-api-rd-facilities-300812/ 2012-08-30T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/qps-buys-major-stake-in-jsw-life-sciences-300812/ 2012-08-30T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/aerial-narcolepsy-drug-gains-fda-orphan-drug-status-300812/ 2012-08-30T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-proacta-ind-application-for-pr610-300812/ 2012-08-30T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/prana-parkinsons-drug-completes-preclinical-studies-300812/ 2012-08-30T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/acelrx-small-volume-oral-transmucosal-dosage-forms-wins-new-us-patents-300812/ 2012-08-30T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-discards-new-schizophrenia-drug-clinical-studies-300812/ 2012-08-30T08:48:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/pgxl-suregene-unveil-new-antipsychotic-and-antidepressant-test-300812/ 2012-08-30T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-zytiga-snda-receives-fda-priority-review-300812/ 2012-08-30T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-seeks-regorafenib-new-drug-application-approval-310812/ 2012-08-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/life-technologies-sino-biological-partner-for-product-development-310812/ 2012-08-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-to-pay181m-to-settle-risperdal-drug-marketing-issues-310812/ 2012-08-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/private-label-nutraceuticals-expands-its-gmp-certified-facility-310812/ 2012-08-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/acceleron-pharma-to-deploy-qumas-regulatory-documents-solution-3100812/ 2012-08-30T23:24:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-genmab-sign-daratumumab-license-development-agreement-310812/ 2012-08-31T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-introduces-generic-irbesartan-tablets-310812/ 2012-08-31T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-reports-positive-results-from-phase-1b-trial-of-rivax-310812/ 2012-08-31T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-seeks-fda-orphan-drug-status-for-plx-cells-310812/ 2012-08-31T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/sensient-names-alejandro-ballesteros-as-president-of-dehydrated-flavors-310812/ 2012-08-31T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/quest-launches-molecular-cervical-cancer-terc-test-310812/ 2012-08-31T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/hrs-to-present-heat-exchange-solutions-at-pharmac-india-310812/ 2012-08-31T09:11:00+00:00 https://www.pharmaceutical-business-review.com/news/us-dod-extends-tekmira-temporary-stop-work-order-030812/ 2012-09-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/prime-india-healthcare-to-introduce-electronic-health-cards-in-india-030912/ 2012-09-02T21:27:00+00:00 https://www.pharmaceutical-business-review.com/news/sacred-heart-installs-talyst-pharmacy-automation-solution-030912/ 2012-09-02T21:31:00+00:00 https://www.pharmaceutical-business-review.com/news/agios-penn-sign-intellectual-property-licensing-deal-030912/ 2012-09-03T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-astellas-announce-fda-approval-for-xtandi-030912/ 2012-09-03T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/vlst-pfizer-sign-in-licensing-agreement-for-oncology-compound-030912/ 2012-09-03T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/sophiris-bph-drug-demonstrates-safe-transrectal-delivery-030912/ 2012-09-03T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/biofocus-ono-enter-into-new-drug-discovery-agreement-030912/ 2012-09-03T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/genspera-receives-clearance-for-g-202-phase-ii-trial-in-uk-030912/ 2012-09-03T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/dna20-enters-into-strategic-alliance-with-aldevron-030912/ 2012-09-03T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/elevation-reports-positive-golden-1-copd-study-data-030912/ 2012-09-03T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-shoppe-to-open-new-us-distribution-center-030912/ 2012-09-03T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/azzur-labs-unveils-new-lab-in-us-030912/ 2012-09-03T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/galectin-therapeutics-to-move-headquarters-to-atlanta-030912/ 2012-09-03T08:50:00+00:00 https://www.pharmaceutical-business-review.com/news/gemini-to-market-insiders-smart-fix-products-in-india-040812/ 2012-09-03T21:49:00+00:00 https://www.pharmaceutical-business-review.com/news/ramcon-as-biosampling-systems-sign-distribution-agreement-040912/ 2012-09-03T21:56:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-ema-approval-for-investigational-tb-drug-040912/ 2012-09-04T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/canada-to-invest-in-biopharmaceuticals-and-vaccines-production-040812/ 2012-09-04T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/hindustan-antibiotics-restarts-saline-production-in-india-040912/ 2012-09-04T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/stemcells-announces-hucns-sc-product-positive-phase-iii-interim-data-040912/ 2012-09-04T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-wins-fda-approval-for-new-dosage-strength-of-exelon-patch-040912/ 2012-09-04T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-inlyta-oral-therapy-wins-european-marketing-authorization-040912/ 2012-09-04T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-introduces-new-modular-biopharmaceutical-factory-040912/ 2012-09-04T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/raysearch-unveils-new-version-of-raystation-system-050912/ 2012-09-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-selects-dr-reddys-for-prurisol-manufacturing-050912/ 2012-09-05T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/niaaa-funds-for-acetaminophen-overdose-induced-liver-failure-treatment-study-050912/ 2012-09-05T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-receives-nci-grant-to-advance-phase-2-trial-of-orbec-050912/ 2012-09-05T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-launches-new-otc-medication-for-migraine-treatment-050912/ 2012-09-05T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/west-janssen-biotech-collaborate-for-new-self-injection-product-050912/ 2012-09-05T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/nida-approves-ucla-phase-2-study-of-medicinova-mn-166-050912/ 2012-09-05T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sarepta-wins-us-contract-to-evaluate-avi-7288-050912/ 2012-09-05T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/scynexis-signs-licensing-deal-with-dechra-for-scy-641-050912/ 2012-09-05T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/pulmatrix-names-robert-clarke-as-new-ceo-050912/ 2012-09-05T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/gvk-nci-sign-biomarker-database-licensing-deal-050912/ 2012-09-05T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-pfizer-bosulif-cancer-drug-050912/ 2012-09-05T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-to-supply-arv-drugs-to-indian-aids-control-organization-050912/ 2012-09-05T08:36:00+00:00 https://www.pharmaceutical-business-review.com/news/open-monoclonal-wuxi-pharma-to-develop-therapeutic-antibody-candidates-050912/ 2012-09-05T08:56:00+00:00 https://www.pharmaceutical-business-review.com/news/bellwyck-to-buy-patheon-secondary-clinical-packaging-and-distribution-business-060912/ 2012-09-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/wockhardt-receives-marketing-approval-for-anti-depression-drug-060912/ 2012-09-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-alvine-celiac-disease-therapeutic-060912/ 2012-09-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lycored-starts-chinese-premix-plant-120912/ 2012-09-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-begins-phase-i-cancer-trial-of-anti-mif-antibody-060912/ 2012-09-06T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvo-research-secures-additional-patent-protection-for-pennsaid-2-060912/ 2012-09-06T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/extedo-unveils-new-version-of-validation-solution-060912/ 2012-09-06T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-recommends-novartis-tip-for-cystic-fibrosis-treatment-060912/ 2012-09-06T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/csc-nhs-renew-healthcare-agreement-060912/ 2012-09-06T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/biotage-launches-new-single-channel-microwave-peptide-synthesizer-060912/ 2012-09-06T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/insite-unveils-durasite-2-ophthalmic-drug-delivery-system-060912/ 2012-09-06T03:31:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-commences-phase-ii-study-of-avp-923-060912/ 2012-09-06T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/kythera-completes-enrolment-in-refine-1-refine-2-trials-of-atx-101-060912/ 2012-09-06T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-buy-medicis-pharmaceutical-060912/ 2012-09-06T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/canada-clears-cardiocomm-heartcheck-ecg-pen-070912/ 2012-09-06T21:55:00+00:00 https://www.pharmaceutical-business-review.com/news/symphogen-merck-sign-licensing-deal-for-sym004-070912/ 2012-09-07T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-files-oms824-ind-with-fda-070912/ 2012-09-07T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/life-line-selects-polymer-cardiochek-test-system-070912/ 2012-09-07T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eth-zurich-collaborate-on-diabetes-obesity-research-070912/ 2012-09-07T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/oncothyreon-expands-phase-2-trial-of-pi-3-kinase-inhibitor-px-866-070912/ 2012-09-07T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-wins-fda-clearance-for-sgx203-ind-070912/ 2012-09-07T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-seeks-fda-approval-for-latuda-070912/ 2012-09-07T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/aduro-receives-cdmrp-grant-to-develop-prostate-cancer-vaccine-070912/ 2012-09-07T08:43:00+00:00 https://www.pharmaceutical-business-review.com/news/ventana-develops-dual-stain-cancer-detection-technique-070912/ 2012-09-07T08:49:00+00:00 https://www.pharmaceutical-business-review.com/news/positron-jubilant-partner-to-supply-sr82-rb82-generators-070912/ 2012-09-07T08:58:00+00:00 https://www.pharmaceutical-business-review.com/news/intertek-unveils-medical-device-polymer-testing-toolbox-service-100912/ 2012-09-10T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/sfj-pfizer-partner-to-co-develop-lung-cancer-drug-100912/ 2012-09-10T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fgscda-develops-new-drug-information-software-100912/ 2012-09-10T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/galenea-wins-3m-grant-to-develop-eeg-based-biomarkers-for-schizophrenia-100912/ 2012-09-10T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-to-take-over-jazz-womens-health-business-100912/ 2012-09-10T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-settles-detrol-la-patent-litigation-100912/ 2012-09-10T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-delays-decision-on-salixpharma-diarrhea-drug-100912/ 2012-09-10T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/julphar-opens-new-insulin-plant-in-uae-110912/ 2012-09-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-unveils-generic-tolterodine-capsules-110912/ 2012-09-11T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-anti-hypertension-capsules-receive-fda-approval-110912/ 2012-09-11T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-us-plant-resumes-drug-production-110912/ 2012-09-11T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-launches-instrument-control-software-on-q-exactive-ms-110912/ 2012-09-11T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-wuxi-apptec-to-develop-new-biologic-for-china-110912/ 2012-09-11T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/astex-begins-at13387-04-prostate-cancer-study-110912/ 2012-09-11T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-injection-receives-fda-complete-response-letter-110912/ 2012-09-11T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/astex-crt-institute-of-cancer-research-sign-epigenetic-research-partnership-100912/ 2012-09-11T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-implements-new-disposable-technology-110912/ 2012-09-11T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/stemcells-wins-20m-cirm-award-for-alzheimers-disease-program-110912/ 2012-09-11T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/biocon-to-construct-manufacturing-plant-in-india-110912/ 2012-09-11T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/cml-to-expand-us-api-manufacturing-facility-110912/ 2012-09-11T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/study-says-dha-dietary-supplement-benefits-school-children-110912/ 2012-09-11T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/pbb-licenses-polytherics-therapeg-technology-to-develop-haemophilia-a-treatment-120912/ 2012-09-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-announces-new-formulation-patent-for-xyrem-120912/ 2012-09-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bruker-introduces-new-biopharmaceutical-characterization-solution-140912/ 2012-09-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cbaysystems-renames-as-mmodal-global-services-140912/ 2012-09-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-unveils-high-blood-pressure-tablets-in-us-120912/ 2012-09-12T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/otc-drug-ads-contain-less-information-about-risks-study-120912/ 2012-09-12T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-unveils-new-formulation-of-b-nexa-rx-prenatal-vitamin-120912/ 2012-09-12T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-the-broad-institute-collaborate-to-develop-anti-infective-agents-120912/ 2012-09-12T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-wins-us-government-contract-for-influenza-vaccines-120912/ 2012-09-12T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-continues-increlex-supply-in-us-120912/ 2012-09-12T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-unveils-ondansetron-injection-usp-120912/ 2012-09-12T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/eaton-to-develop-transdermal-patch-delivery-system-120912/ 2012-09-12T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/santarus-phase-iii-travelers-diarrhoea-study-meets-primary-endpoint-120912/ 2012-09-12T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/west-unveils-bsafe-syringe-system-120912/ 2012-09-12T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/illumina-unveils-upgraded-genome-sequence-service-120912/ 2012-09-12T08:37:00+00:00 https://www.pharmaceutical-business-review.com/news/winthrop-university-hospital-islet-sign-beta-cell-technology-agreement-120912/ 2012-09-12T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-builds-new-russian-pharma-production-facility-140912/ 2012-09-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/coti-delmar-to-develop-small-molecules-140912/ 2012-09-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-unveils-new-pipetting-system-140912/ 2012-09-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mov-fas-tni-biotech-to-build-pharma-plant-in-nicaragua-130912/ 2012-09-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/creative-edge-nutrition-acquires-online-store-140912/ 2012-09-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-zhejiang-hisun-launch-joint-venture-130912/ 2012-09-13T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/insmed-names-new-president-chief-executive-officer-130912/ 2012-09-13T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/islet-sciences-signs-license-agreement-with-ucla-130912/ 2012-09-13T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/mesoblast-to-deploy-medidata-cloud-based-technology-130912/ 2012-09-13T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/xcelience-to-commission-new-us-drug-development-facility-130912/ 2012-09-13T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/sartorius-opens-new-production-plant-for-bioreactors-130912/ 2012-09-13T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/cti-initiates-european-launch-of-pixuvri-130912/ 2012-09-13T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-genmark-rvp-test-130912/ 2012-09-13T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-genzyme-aubagio-ms-therapy-130912/ 2012-09-13T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/scripsamerica-to-acquire-marlex-us-facility-130912/ 2012-09-13T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/enzymotec-reports-positive-result-from-infant-nutrition-trials-130912/ 2012-09-13T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-unveils-improved-prenatal-vitamin-capsule-130912/ 2012-09-13T08:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-ethypharm-signzertane-drug-production-agreement-130912/ 2012-09-13T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/magellan-launches-drug-management-solution-140912/ 2012-09-13T22:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-malaysia-to-set-up-greenfield-manufacturing-facility-140912/ 2012-09-14T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/transcept-completes-enrolment-in-phase-2-ocd-trial-140912/ 2012-09-14T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-astellas-launch-xtandi-capsules-140912/ 2012-09-14T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/stemgenesis-to-market-vitro-products-in-china-140912/ 2012-09-14T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ab-sciex-launches-new-liquid-chromatography-instrument-140912/ 2012-09-14T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/medizone-completes-delivery-of-initial-asepticsure-production-units-to-c3-140912/ 2012-09-14T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-takes-over-one-lambda-140912/ 2012-09-14T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/vertellus-names-new-distributor-in-us-west-southwest-140912/ 2012-09-14T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/allele-scientists-advance-human-stem-cells-production-technology-180912/ 2012-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fusion-to-market-unisys-cloud-based-software-solutions-170912/ 2012-09-17T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-laboratories-teva-settle-concerta-litigation/ 2012-09-17T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lannett-anda-for-butalbital-acetaminophen-and-caffeine-tablets-170912/ 2012-09-17T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-commences-phase-ii-study-of-gbr-500-for-ulcerative-colitis-170912/ 2012-09-17T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/pulmatrix-cfft-partner-to-advance-pur118-clinical-trials-170/ 2012-09-17T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/osmotica-pharma-signs-collaboration-agreement-with-panacea-biotec-170912/ 2012-09-17T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/mhra-cautions-diabetic-patients-against-wockhardt-uk-insulin-cartridges-170912/ 2012-09-17T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/creative-edge-to-launch-cenergy-products-at-us-olympia-170912/ 2012-09-17T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/oncolytics-reolysin-first-stage-phase-2-trial-meets-primary-endpoint-170912/ 2012-09-17T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/certified-nutraceuticals-files-patent-application-for-reverse-vine-extract-170912/ 2012-09-17T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-dara-sign-licensing-agreement-for-gelclair-170912/ 2012-09-17T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/monosol-to-develop-migraine-drug-candidate-170912/ 2012-09-17T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-pharma-licenses-ucl-business-new-drug-delivery-platform-170912/ 2012-09-17T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/bionomics-acquires-eclipse-therapeutics-170912/ 2012-09-17T08:52:00+00:00 https://www.pharmaceutical-business-review.com/news/medistem-completes-first-phase-of-diabetes-technology-project-170912/ 2012-09-17T09:10:00+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-anti-cancer-drug-advances-to-next-stage-trials-170912/ 2012-09-17T09:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-cautions-about-otc-pain-relievers-causing-burning-pain-210912/ 2012-09-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lifeline-new-software-wins-us-patent-180912/ 2012-09-17T23:27:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-seeks-synflorix-additional-indication-approval-in-europe-180912/ 2012-09-18T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/targacept-phase-2-adhdi-trial-fails-to-meet-primary-outcome-180912/ 2012-09-18T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-millipore-signs-agreement-to-license-aj-ips-cell-patent-portfolio-180912/ 2012-09-18T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/jennerex-phase-2-trial-of-jx594-meets-key-clinical-endpoints-180912/ 2012-09-18T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-offers-new-histone-reagents-180912/ 2012-09-18T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/mednet-launches-improved-eclinical-solution-180912/ 2012-09-18T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/proimmune-unveils-new-in-vitro-cytokine-release-assay-180912/ 2012-09-18T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/america-stem-cell-wins-sttr-grant-180912/ 2012-09-18T09:14:00+00:00 https://www.pharmaceutical-business-review.com/news/aprea-presents-apr-246-drug-positive-results-200912/ 2012-09-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-unveils-obesity-management-capsule-in-us-190912/ 2012-09-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-grants-approval-for-wockhardts-peptic-ulcers-drug-190912/ 2012-09-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-mumps-vaccine-production-facility-receives-gmp-certificate-190912/ 2012-09-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-to-close-s1-production-facility-190912/ 2012-09-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-to-develop-acinetobacter-antibodies-treatment-200912/ 2012-09-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-unveils-combivent-respimat-drug-in-us-190912/ 2012-09-19T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/nci-grants-sbir-grant-to-eutropics-for-bh3-profiling-assay-development-190912/ 2012-09-19T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/synta-reports-interim-results-from-galaxy-trial-190912/ 2012-09-19T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-oxigene-join-forces-for-anaplastic-thyroid-cancer-drug-clinical-trial-190912/ 2012-09-19T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/harbour-shangpharma-sign-antibodies-development-agreement-190912/ 2012-09-19T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hebron-launches-new-natural-gastric-distress-products-190912/ 2012-09-19T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/thermogenesis-signs-new-distribution-agreements-for-cord-blood-products-200912/ 2012-09-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/first-coast-oncology-deploys-raystation-system-200912/ 2012-09-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ten-pharma-companies-join-hands-to-expedite-new-medicines-development-200912/ 2012-09-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ten-biopharmaceutical-companies-team-to-advance-pharmaceutical-research-200912/ 2012-09-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/usbiological-akrivis-to-co-develop-z-tect-technology-products-200912/ 2012-09-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-onconova-sign-rigosertib-licensing-deal-200912/ 2012-09-20T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-innopharma-acetylcysteine-solution-usp-20-200912/ 2012-09-20T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pt-tanabe-indonesia-launches-simponi-subcutaneous-injection-200912/ 2012-09-20T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-to-sarepta-for-anti-viral-drugs-development-200912/ 2012-09-20T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/institute-of-cancer-research-installs-dotmatics-data-visualization-tool-200912/ 2012-09-20T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/micropharma-seeks-patent-protection-for-probiotic-technologies-200912/ 2012-09-20T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-begins-phase-3-dlbcl-trial-of-zevalin-200912/ 2012-09-20T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/gamida-completes-enrolment-in-phase-iii-study-of-nicord-200912/ 2012-09-20T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/protein-potential-aduro-win-sbir-grant-for-malaria-vaccines-development-200912/ 2012-09-20T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/quidel-immunoassay-system-receives-ce-mark-210912/ 2012-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/imprimis-begins-clinical-study-of-topical-pain-relieving-cream-210912/ 2012-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/jhp-signs-lyophilized-biologic-supply-agreement-210912/ 2012-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nimh-awards-antibodies-development-grant-to-omeros-210912/ 2012-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-study-confirms-safety-of-nanobody-drug-210912/ 2012-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-kek-sign-ntds-collaborative-research-agreement-210912/ 2012-09-21T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-wins-nih-small-molecule-repository-contract-210912/ 2012-09-21T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-merck-advance-alx-0751-into-pre-clinical-development-210912/ 2012-09-21T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-inaugurates-new-biological-center-in-lithuania-210912/ 2012-09-21T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/gns-healthcare-join-forces-with-covance-for-computer-models-development-210912/ 2012-09-21T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/uthr-ascendis-collaborate-for-self-injectable-pah-medication-210912/ 2012-09-21T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/omkar-to-expand-api-production-capacity-in-india-210912/ 2012-09-21T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/enwave-enters-into-collaboration-agreement-with-second-pharma-company-240912/ 2012-09-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-to-implement-revitas-flex-technology-platform-240912/ 2012-09-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-releases-new-reporting-and-analytics-solution-240912/ 2012-09-24T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/usfda-approves-mylan-meclizine-hydrochloride-anda-240912/ 2012-09-24T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-and-vanderbilt-university-to-develop-parkinsons-disease-therapies-240912/ 2012-09-24T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/uluru-to-launch-altrazeal-in-austria-240912/ 2012-09-24T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/procter-gamble-unveils-new-flavor-coated-heartburn-pill-240912/ 2012-09-24T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-pfizer-announce-chmp-positive-opinion-for-eliquis-240912/ 2012-09-24T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-regeneron-new-iso-osmotic-ophthalmic-injection-240912/ 2012-09-24T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-mylan-valsartan-and-hydrochlorothiazide-tablets-240912/ 2012-09-24T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cytochroma-initiates-vitamin-d-prohormone-therapy-phase-iii-study-240912/ 2012-09-24T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/eurofins-to-acquirepan-labs-pharmacology-unit-240912/ 2012-09-24T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/njm-packaging-to-unveil-new-tablet-counter-machine-240912/ 2012-09-24T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-selects-onpoint-system-for-clinical-management-250912/ 2012-09-25T00:25:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-to-expand-science-facilities-in-beijing-250912/ 2012-09-25T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/aegis-wins-us-patent-for-triptan-nasal-spray-formulations-250912/ 2012-09-25T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-signs-oravig-licensing-contract-with-vestiq-250912/ 2012-09-25T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-takes-over-visudyne-from-qlt-250912/ 2012-09-25T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/rxi-completes-dosing-in-rxi-109-phase-1-study-250912/ 2012-09-25T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/alchem-expands-sennosides-facility-production-capacity-in-india-250912/ 2012-09-25T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/versartis-reports-positive-results-from-phase-1-trial-of-vrs-317-250912/ 2012-09-25T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/nsg-group-to-use-bruker-atomic-force-microscope-250912/ 2012-09-25T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-seeks-fda-approval-for-tacrolimus-tablets-250912/ 2012-09-25T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-funds-biodel-for-glucagon-formulations-development-250912/ 2012-09-25T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-to-begin-clinical-trials-for-anti-cancer-drug-250912/ 2012-09-25T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-uk-facility-to-manufacture-epilepsy-drug-240912/ 2012-09-25T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/gpma-urges-government-to-supply-potable-water-for-drug-manufacturing-260912/ 2012-09-26T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/gynecor-unveils-new-laboratory-technology-260912/ 2012-09-26T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-status-for-sucampo-takeda-constipation-drug-260912/ 2012-09-26T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-approves-tigenix-netherland-facility-for-chondrocelect-production-250912/ 2012-09-26T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/wolters-enhances-sentri7-surveillance-solution-260912/ 2012-09-26T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-novabay-commence-phase-2b-study-of-nvc-422-260912/ 2012-09-26T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-millennium-complete-patient-enrolment-in-phase-iii-trial-of-adcetris-260912/ 2012-09-26T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/revolution-labs-launches-new-weight-loss-diet-supplement-260912/ 2012-09-26T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/atreca-uses-immune-repertoire-capture-technology-to-develop-new-vaccines-260912/ 2012-09-26T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-reaches-milestone-in-boehringer-research-alliance-260912/ 2012-09-26T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-extends-bl-1020-patent-rights-260912/ 2012-09-26T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-sues-fda-over-gralise-orphan-drug-exclusivity-patent-delay-260912/ 2012-09-26T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/life-launches-new-lung-cancer-detector-260912/ 2012-09-26T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/epo-grants-patent-to-aeterna-aezs-130-drug-270912/ 2012-09-27T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/philip-medicago-sign-influenza-vaccine-technology-license-agreement-270912/ 2012-09-27T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-return-heart-drug-rights-to-cardiome-pharma-270912/ 2012-09-27T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/mhra-completes-inspection-of-almac-clinical-services-facility-270912/ 2012-09-27T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/raybiotech-signs-license-agreement-with-emory-270912/ 2012-09-27T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/medeanalytics-upgrades-analytics-platform-270912/ 2012-09-27T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/abaxis-settles-patent-litigation-with-cepheid-270912/ 2012-09-27T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/anil-bioplus-to-build-new-indian-manufacturing-plant-270912/ 2012-09-27T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/teijin-to-develop-and-market-bronchial-asthma-drug-in-japan-270912/ 2012-09-27T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-accepts-ffvi-drug-nda-submission-270912/ 2012-09-27T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-funds-nvc-422-development-270912/ 2012-09-27T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/accenture-completes-purchase-of-octagon-research-280912/ 2012-09-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/repligen-begins-phase-1b-study-of-rg3039-280912/ 2012-09-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-completes-phase-iii-studies-of-nintedanib-280912/ 2012-09-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/neurocog-receives-grant-from-nih-280912/ 2012-09-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fisher-bioservices-to-distribute-plx-cell-therapies-280912/ 2012-09-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/life-technologies-receives-fda-clearence-for-optmizer-t-cell-growth-medium-280912/ 2012-09-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cedarburg-expands-us-api-facility-production-capacity-280912/ 2012-09-28T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/medicure-develops-aggrastat-transdermal-delivery-formulation-280912/ 2012-09-28T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-noa-to-alitair-resin-formulated-cough-product-280912/ 2012-09-28T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/avid-bioservices-receives-hiv-vaccine-development-contract-280912/ 2012-09-28T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-unveils-montelukast-sodium-oral-granules-280912/ 2012-09-28T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-laboratories-submits-antidepressant-drug-nda-280912/ 2012-09-28T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/endocyte-folic-acid-solution-for-injection-wins-orphan-drug-status-280912/ 2012-09-28T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-aspireo-in-somatostatin-analogue-development-agreement-280912/ 2012-09-28T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-to-develop-antibody-drug-conjugate-280912/ 2012-09-28T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-reports-phase-ii-results-for-ramucirumab-011012/ 2012-09-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/heuer-md-research-announces-global-launch-of-cardiashred-supplement-011012/ 2012-09-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/threshold-releases-preliminary-study-results-of-th-302-in-combination-with-bevacizumab-011012/ 2012-10-01T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-irbesartan-anda-011012/ 2012-10-01T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/tpg-takes-over-par-pharmaceutical-011012/ 2012-10-01T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-partners-with-scottish-health-boards-to-advance-clinical-research-011012/ 2012-10-01T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-abbott-humira-as-ulcerative-colitis-therapy-011012/ 2012-10-01T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-launches-vancomycin-hydrochloride-for-injection-011012/ 2012-10-01T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-renews-manufacturing-and-supply-agreement-with-thepharmanetwork-011012/ 2012-10-01T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-bayer-join-forces-for-endometriosis-drugs-development-011012/ 2012-10-01T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/kaketsuken-uses-medidata-solutions-for-clinical-trials-021012/ 2012-10-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-to-relocate-pharma-ingredients-and-services-headquarters-to-us-021012/ 2012-10-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pureform-launches-new-multi-vitamin-shot-021012/ 2012-10-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-to-integrate-elsevier-reaxys-workflow-solution-021012/ 2012-10-01T21:05:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-approves-eylea-injection-011012/ 2012-10-02T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-lundbeck-submit-vortioxetine-nda-to-fda-021012/ 2012-10-02T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-reports-positive-results-from-stelara-studies-021012/ 2012-10-02T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/medistem-superview-collaborate-on-therapeutics-development-021012/ 2012-10-02T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-astellas-enter-into-asp015k-license-agreement-021012/ 2012-10-02T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/church-dwight-takes-over-avid-health-021012/ 2012-10-02T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-aldrich-plans-to-expand-operations-in-scotland-021012/ 2012-10-02T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/biophytis-raises-2m-in-series-b-funding-round-021012/ 2012-10-02T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-funds-geovax-to-develop-hiv-drug021012/ 2012-10-02T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/tianyin-pharma-plans-to-relocate-manufacturing-plants-to-china-0210012/ 2012-10-02T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/ab-sciex-releases-new-software-application-021012/ 2012-10-02T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-phase-iii-comparz-study-meets-primary-endpoint-031012/ 2012-10-03T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-launches-acetylcysteine-solution-usp-20-031012/ 2012-10-03T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/arqule-daiichi-discontinue-phase-3-marquee-trial-031012/ 2012-10-03T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-celladon-sign-mydicar-gmp-manufacturing-agreement-031012/ 2012-10-03T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-ablynx-partner-to-develop-nanobody-candidates-031012/ 2012-10-03T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/dynaflex-to-provide-packaging-services-to-pharma-industry-031012/ 2012-10-03T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-submits-amended-nda-for-alferon-n-injection-031012/ 2012-10-03T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-catalent-sign-qsymia-supply-agreement-031012/ 2012-10-03T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/avidbiotics-receives-sbir-grant-to-develop-protein-antibacterial-technology-031012/ 2012-10-03T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/colby-pharma-wins-sbir-grant-for-anti-prostate-cancer-drugs-development-031012/ 2012-10-03T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/kane-biotech-usaisr-to-develop-anti-microbial-wound-gel-031012/ 2012-10-03T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-receives-development-milestone-payment-from-pfizer-031012/ 2012-10-03T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/cytocell-unveils-new-molecular-cytogenetic-test-031012/ 2012-10-03T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-bristol-myers-restructure-plavix-avaproavalide-sales-alliance-041012/ 2012-10-04T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/breckenridge-signs-risperidone-marketing-agreement-with-ajanta-pharma-041012/ 2012-10-04T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-launches-apnea-of-prematurity-drug-for-infants-041012/ 2012-10-04T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/phenogen-announces-availability-of-breast-cancer-risk-assessment-test-041012/ 2012-10-04T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-expands-uk-packaging-facility-041012/ 2012-10-04T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/ventirx-celgene-to-develop-cancer-drug-041012/ 2012-10-04T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-patent-notice-of-allowance-for-prolor-hgh-ctp-041012/ 2012-10-04T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-medpace-collaborate-for-oral-insulin-phase-ii-clinical-trial-041012/ 2012-10-04T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/chirhoclin-releases-chirhostim-drug-041012/ 2012-10-04T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-catalent-partner-for-clinical-trial-material-supply-management-041012/ 2012-10-04T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/medpodium-completes-acquisition-of-us-supplement-firm-041012/ 2012-10-04T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/microscan-to-display-new-vision-traceability-solution-041012/ 2012-10-04T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-sigma-tau-new-topical-ophthalmic-therapeutic-041012/ 2012-10-04T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-reports-top-line-results-of-phase-3-prevenar-13-trial-051012/ 2012-10-05T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-anti-cachexia-drug-wins-fda-fast-track-designation-051012/ 2012-10-05T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/proteonomix-wins-irb-approval-for-clinical-trial-of-umk-121-051012/ 2012-10-05T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/akvion-lonza-to-co-market-carnipure-containing-dietary-supplements-051012/ 2012-10-05T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/medicines-company-discontinues-mdco-2010-phase-2b-study-051012/ 2012-10-05T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/rxi-pharmaceuticals-receives-sbir-grant-to-develop-sd-rxrnas-051012/ 2012-10-05T02:55:00+00:00 https://www.pharmaceutical-business-review.com/news/jbi-wolters-kluwer-expand-partnership-for-ovidsp-solution-051012/ 2012-10-05T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-take-over-ligocyte-pharmaceuticals-051012/ 2012-10-05T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-biosolutions-to-advance-anthrax-vaccine-development-051012/ 2012-10-05T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/shionogi-viiv-to-file-hiv-drug-for-approval-051012/ 2012-10-05T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/bend-research-dow-chemical-in-strategic-agreement-051012/ 2012-10-05T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/neurotrack-introduces-early-alzheimers-disease-diagnostic-test-051012/ 2012-10-05T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/telstar-wins-square-pharma-contract-for-new-pharmaceutical-plants-051012/ 2012-10-05T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/qps-holdings-opens-new-facility-in-china-051012/ 2012-10-05T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-halts-clinical-development-of-gsk2251052-081012/ 2012-10-08T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/itl-robert-h-lurie-comprehensive-cancer-center-sign-drug-development-collaboration-081012/ 2012-10-08T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/dotmatics-opens-new-scientific-informatics-solutions-facility-in-germany-081012/ 2012-10-08T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/mannkind-completes-patient-recruitment-in-two-afrezza-phase-3-studies-081012/ 2012-10-08T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/veloxi-chiesi-sign-distribution-contract-for-immunosuppressant-drug-081012/ 2012-10-08T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-pharmaceutical-almac-sign-manufacturing-agreement-in-biocatalysis-081012/ 2012-10-08T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/goose-technologies-unveils-new-proofreader-product-081012/ 2012-10-08T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-watsons-acquisition-of-actavis-081012/ 2012-10-08T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/katama-to-develop-sanochemia-pain-reliever-in-north-america-081012/ 2012-10-08T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/natural-grocers-launches-new-store-in-us-081012/ 2012-10-08T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/marlex-ships-first-order-to-us-department-of-defense-081012/ 2012-10-08T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/brenton-introduces-new-side-load-case-packer-081012/ 2012-10-08T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmachem-launches-new-diabetes-management-product-081012/ 2012-10-08T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-expands-manufacturing-operations-in-uk-091012/ 2012-10-09T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-to-launch-new-production-line-at-mangalore-manufacturing-facility-091012/ 2012-10-09T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/inclin-nextrials-join-forces-to-deliver-clinical-research-services-091012/ 2012-10-09T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-ardelyx-sign-licensing-agreement-for-nhe3-inhibitor-programme-091012/ 2012-10-09T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-reaches-milestone-under-drug-discovery-collaboration-with-novartis-081012/ 2012-10-09T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/mucosis-crucell-sign-research-license-option-agreement-091012/ 2012-10-09T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/taam-teva-launches-soylife-based-menopause-supplement-in-israel-091012/ 2012-10-09T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-use-stabyexpress-technology-091012/ 2012-10-09T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/kaneka-launches-new-protein-a-chromatography-resin-091012/ 2012-10-09T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/genetic-immunity-manufacturing-facility-wins-gmp-approval-091012/ 2012-10-09T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/leiter-rx-to-use-imd-a-rapid-microbial-monitoring-system-091012/ 2012-10-09T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/edgemont-launches-new-higher-dose-bupropion-extended-release-tablets-091012/ 2012-10-09T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-announces-phase-3-solanezumab-expedition-studies-results-091012/ 2012-10-09T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/cellerant-receives-sbir-contract-to-develop-anti-cancer-therapy-111012/ 2012-10-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/encap-qub-to-collaborate-on-hot-melt-extrusion-technology-111012/ 2012-10-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/wolters-releases-ceconnection-solution-for-allied-health-professionals-101012/ 2012-10-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-introduces-generic-evoxac-in-us-101012/ 2012-10-10T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-mgh-enter-into-oncology-research-collaboration-101012/ 2012-10-10T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-begins-phase-2-rsv-vaccine-trial-101012/ 2012-10-10T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-extends-spectrum-folotyn-patent-for-five-years-101012/ 2012-10-10T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/vitiva-opens-vitiva-analytical-services-101012/ 2012-10-10T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/intellicell-manufactures-svf-cells-from-non-living-donated-adipose-tissue-101012/ 2012-10-10T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-unveil-re-usable-insulin-pen-in-india-101012/ 2012-10-10T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-receives-scale-up-manufacturing-protocol-for-anti-cancer-compound-101012/ 2012-10-10T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/symbiosis-opens-sterile-drug-manufacturing-facility-in-scotland-101012/ 2012-10-10T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/tessenderlo-plans-to-sell-pharma-ingredients-plants-101012/ 2012-10-10T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/uniquest-aquavit-sign-mou-for-pito-001-manufacturing-101012/ 2012-10-10T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxxas-names-david-hoey-as-new-ceo-101012/ 2012-10-10T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/veladx-life-tech-in-new-sequencing-based-ivd-tests-development-agreement-101012/ 2012-10-10T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-announces-positive-phase-iii-gala-study-results-111012/ 2012-10-11T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-signs-contract-to-produce-ipscs-for-regenerative-medicine-111012/ 2012-10-11T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-to-offer-pre-clinical-screening-packages-111012/ 2012-10-11T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/medgenesis-wins-grant-to-advance-gdnf-development-111012/ 2012-10-11T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/amplion-research-unveils-biomarkerbase-111012/ 2012-10-11T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-launches-phase-3-pancreatic-cancer-study-111012/ 2012-10-11T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/rbcc-amarantus-to-commercialise-parkinsons-diagnostic-platform-111012/ 2012-10-11T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-in-patent-settlement-with-shionogi-cima-for-prednisolone-odt-111012/ 2012-10-11T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/labcorp-to-expand-us-sale-of-mitomics-pcmt-kit-111012/ 2012-10-11T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-actavis-generic-cardiovascular-drug-111012/ 2012-10-11T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-reports-positive-top-line-results-from-phase-3-pain-study-of-alo-02-121012/ 2012-10-12T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/act-wins-sbir-grant-to-advance-anticancer-drug-development-121012/ 2012-10-12T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/bend-research-wins-us-patents-covering-solubility-enhancing-technologies-121012/ 2012-10-12T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/avery-dennison-releases-new-anti-counterfeiting-technology-121012/ 2012-10-12T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/strike-axe-appoints-root-as-new-chief-executive-officer-121012/ 2012-10-12T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/euthymics-completes-enrolment-in-triade-study-121012/ 2012-10-12T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/scripsamerica-signs-new-distribution-deal-with-generic-pharmaceutical-company-121012/ 2012-10-12T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-opens-new-packaging-facility-in-indonesia-121012/ 2012-10-12T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/novasep-to-build-chromatography-plant-in-france-121012/ 2012-10-12T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/iverson-johns-hopkins-in-molecular-diagnostics-test-license-agreement-121012/ 2012-10-12T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-perrigo-otc-nicotine-mint-flavored-mini-lozenge-anda-121012/ 2012-10-12T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/premier-to-distribute-make-me-drinks-vitamin-supplement-121012/ 2012-10-12T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/sarc-gets-115m-grant-for-sarcoma-translational-research-151012/ 2012-10-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dkfzgenetic-immunity-to-develop-hpv-therapeutic-vaccine-151012/ 2012-10-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/stemcells-receives-us-patent-for-liver-cells-151012/ 2012-10-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-presents-aubagio-trial-data-151012/ 2012-10-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-abraxane-to-treat-lung-cancer-151012/ 2012-10-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/epiomed-to-develop-spray-formulation-for-motion-sickness-181012/ 2012-10-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaron-astrazeneca-sign-multi-year-drug-discovery-partnership-151012/ 2012-10-15T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/recipharm-wins-development-manufacturing-deal-from-astimex-151012/ 2012-10-15T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-aicuris-sign-licensing-deal-for-hcmv-investigational-medicines-151012/ 2012-10-15T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-watson-laboratories-generic-sanctura-anda-151012/ 2012-10-15T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-begins-phase-1-pah-trial-of-apd811-151012/ 2012-10-15T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/sqi-diagnostic-unveils-automated-sqidlite-multiplexing-system-151012/ 2012-10-15T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-noa-to-skyepharma-rayos-delayed-release-tablets-151012/ 2012-10-15T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-baraclude-labeling-update-161012/ 2012-10-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ftc-approves-watsons-acquisition-of-actavis/ 2012-10-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/polytherics-to-further-assess-polypeg-applications-161012/ 2012-10-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-oxford-to-use-expres2-technology-161012/ 2012-10-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cyprotex-to-use-compozr-zinc-finger-nuclease-technology-161012/ 2012-10-16T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-regard-trial-meets-primary-endpoint-161012/ 2012-10-16T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/ark-therapeutics-to-manufacture-lymfactin-161012/ 2012-10-16T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/bdsi-announces-launch-of-cancer-pain-therapy-in-eu-161012/ 2012-10-16T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/nexira-takes-over-european-botanicals-extracting-firm-161012/ 2012-10-16T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/creative-edge-nutrition-buys-chesapeake-nutraceuticals-161012/ 2012-10-16T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/biostar-to-manufacture-supply-five-additional-drugs-to-xijing-hospital-161012/ 2012-10-16T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-completes-patient-enrollment-in-phase-2-trial-of-imo-3100-161012/ 2012-10-16T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/novimmune-receives-ec-grant-for-ni-0501-development-161012/ 2012-10-16T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-noa-to-arrowhead-new-dpc-sirna-delivery-system-161012/ 2012-10-16T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-sells-womens-health-business-to-meda-161012/ 2012-10-16T08:48:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-tau-unveils-new-paediatric-probiotic-171012/ 2012-10-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cegedim-releases-mobile-intelligence-8-platform-170912/ 2012-10-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/statistics-data-selects-mednet-imednet-edc-solution-171012/ 2012-10-16T21:46:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-merck-partner-to-develop-cardiovascular-therapeutics-171012/ 2012-10-17T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/arqule-signs-spa-agreement-with-fda-for-phase-3-hcc-trial-171012/ 2012-10-17T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aifa-awards-medicines-evaluation-systems-contract-to-accenture-171012/ 2012-10-17T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-bioresearch-wins-idiq-contract-from-nih-171012/ 2012-10-17T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/unilife-develops-new-opthalmic-drug-delivery-technologies-171012/ 2012-10-17T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-seeks-approval-for-turoctocog-alfa-in-europe-us-171012/ 2012-10-17T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-utah-develops-90-day-intravaginal-ring-for-hiv-drug-delivery-171012/ 2012-10-17T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/breckenridge-to-market-gabapentin-capsules-171012/ 2012-10-17T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/rubicon-avantor-to-develop-new-gastro-retentive-excipient-171012/ 2012-10-17T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-packaging-unveils-new-cleaning-system-for-pharma-companies-171012/ 2012-10-17T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/charles-river-astrazeneca-partner-to-accelerate-drug-development-181012/ 2012-10-18T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eli-lilly-alimta-as-continuation-maintenance-therapy-for-ns-nsclc-181012/ 2012-10-18T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-pandemic-influenza-vaccine-meets-endpoints-in-two-phase-1-trials-181012/ 2012-10-18T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-otc-generic-heartburn-drug-anda-wins-fda-tentative-approval-181012/ 2012-10-18T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-inlyta-fails-to-meet-primary-endpoint-in-phase-3-study-181012/ 2012-10-18T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-thrombogenics-vitreomacular-adhesion-therapy-181012/ 2012-10-18T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-labs-to-buy-sms-indian-manufacturing-unit-181012/ 2012-10-18T07:46:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/nsf-certifies-new-amway-sleep-aid-sports-product-181012/ 2012-10-18T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-nci-in-cellular-cancer-therapeutics-development-agreement-181012/ 2012-10-18T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/cpa-global-opens-new-facility-in-germany-191012/ 2012-10-18T22:58:00+00:00 https://www.pharmaceutical-business-review.com/news/medigain-services-takes-over-medbe-191012/ 2012-10-18T22:59:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-us-military-complete-first-year-shipments-of-adenovirus-vaccine-191012/ 2012-10-19T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/sygnis-to-join-force-with-x-pol-for-sustainable-business-model-191012/ 2012-10-19T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/icf-international-wins-5m-contract-from-us-hhs-191012/ 2012-10-19T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-auxogyn-partner-to-develop-eeva-test-191012/ 2012-10-19T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/advantapure-launches-sterilized-disposable-tubing-assemblies-191012/ 2012-10-19T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-shire-us-manufacturing-extend-api-supply-contract-191012/ 2012-10-19T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/tni-biotech-hubei-to-co-develop-new-cancer-therapies-191012/ 2012-10-19T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/tris-pharma-expands-us-operations-191012/ 2012-10-19T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/acutemp-csafe-combine-businesses-to-form-single-entity-191012/ 2012-10-19T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-aist-partner-to-develop-drugs-against-neglected-tropical-diseases-221012/ 2012-10-22T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/abattis-bioceuticlas-signs-loi-with-vertical-design-systems-221012/ 2012-10-22T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/amyvid-wins-positive-chmp-opinion-for-use-in-cognitive-impairment-diagnosis-221012/ 2012-10-22T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-unveils-prostate-cancer-therapy-in-japan-221012/ 2012-10-22T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-labs-to-distribute-dynamiclear-cold-sores-otc-drug-in-canada-221012/ 2012-10-22T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-to-begin-phase-ii-study-of-tasquinimod-in-additional-tumor-types-221012/ 2012-10-22T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-begins-phase-3-mln9708-amyloidosis-trial-221012/ 2012-10-22T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/betmigatm-receives-chmp-recommendation-to-treat-oab-syndrome-221012/ 2012-10-22T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-kurvelo-contraceptive-tablets-221012/ 2012-10-22T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-opens-new-cgmp-biologics-manufacturing-facility-in-china-221012/ 2012-10-22T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/csp-technologies-unveils-activ-blister-packaging-for-pharmaceuticals-221012/ 2012-10-22T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-consider-faster-approval-process-for-life-saving-drugs-221012/ 2012-10-22T08:56:00+00:00 https://www.pharmaceutical-business-review.com/news/savient-krystexxa-wins-positive-chmp-opinion-221012/ 2012-10-22T09:00:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-genzyme-partner-to-develop-amyloidosis-therapeutics-231012/ 2012-10-23T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-wins-us-patent-for-diabetic-nephropathy-drug-231012/ 2012-10-23T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/amicus-reaches-target-enrollment-in-phase-3-fabry-disease-study-231012/ 2012-10-23T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-reaches-milestone-in-dinaciclib-collaboration-with-merck-231012/ 2012-10-23T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-take-over-nextwave-pharmaceuticals-231012/ 2012-10-23T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/biondvax-completes-qp-gmp-audit-231012/ 2012-10-23T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-nuvo-anesthetic-topical-cream-231012/ 2012-10-23T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-moksha8-partner-for-latin-american-market-231012/ 2012-10-23T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-funds-ptc-to-develop-dengue-treatment-231012/ 2012-10-23T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/labcorp-to-develop-tb-antimicrobial-susceptibility-test-using-b-smart-231012/ 2012-10-23T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eisai-fycompa-drug-to-treat-epileptic-seizures-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-new-patents-to-amarin-ultra-pure-omega-3-fatty-acid-product-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-announces-milestone-in-build-out-of-new-plx-cells-cgmp-facility-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/effrx-announces-us-launch-of-new-buffered-oral-solution-for-osteoporosis-treatment-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-ferring-misoprostol-vaginal-insert-nda-for-review-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-reports-positive-results-from-investigational-riociguat-chest-1-trial-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tigermed-chooses-merge-clinical-trial-management-solution-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-oxtellar-to-treat-epilepsy-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/evaluatepharma-releases-tracking-drugsfda-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-biosciences-introduces-tamoxifen-citrate-in-liquid-form-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/france-launches-new-cell-therapy-manufacturing-facility-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/agenus-begins-phase-2-study-of-herpv-vaccine-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/receptos-begins-phase-23-trial-of-rpc1063-241012/ 2012-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hcps-underestimate-effect-of-specific-ulcerative-colitis-symptoms-on-patients-survey-says-241012/ 2012-10-24T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-reports-laquinimod-phase-iia-trial-positive-results-241012/ 2012-10-24T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/mediomics-receives-in-process-analyzer-development-contract-251012/ 2012-10-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-xalkori-wins-conditional-marketing-authorization-in-eu-251012/ 2012-10-25T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/tonix-pk-study-confirms-effectiveness-of-tnx-102-sublingual-tablet-251012/ 2012-10-25T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/kinematik-joins-forces-with-mobile-cheminformatics-software-tools-provider-251012/ 2012-10-25T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-receives-69m-contract-from-nih-251012/ 2012-10-25T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/anges-signs-agreement-to-obtain-us-marketing-rights-for-mitsubishi-ischemic-drug-251012/ 2012-10-25T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-reports-positive-results-from-anti-cocaine-vaccine-study-251012/ 2012-10-25T02:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ophthotech-anti-pdgf-combination-agent-demonstrates-efficacy-in-phase-2b-study-251012/ 2012-10-25T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-launches-alk-test-in-europe-251012/ 2012-10-25T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-shoppe-to-unveil-new-vitamin-supplement-251012/ 2012-10-25T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/nbty-inaugurates-new-nutritional-bar-manufacturing-facility-in-us-251012/ 2012-10-25T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/taibang-receives-gmp-certificate-from-sfda-251012/ 2012-10-25T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-state-plans-to-construct-drug-manufacturing-plants-251012/ 2012-10-25T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-completes-enrolment-in-hokusai-vte-clinical-study-261012/ 2012-10-26T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-diosyn-piramal-partner-for-adcs-production-261012/ 2012-10-26T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/theraclone-commences-phase-2-influenza-a-study-of-tcn-032-261012/ 2012-10-26T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/evonik-difusion-to-develop-new-medical-polymer-261012/ 2012-10-26T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/csafe-kuehne-nagel-enter-into-master-lease-agreement-261012/ 2012-10-26T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/study-says-low-levels-of-anti-plasma-may-lead-to-vein-graft-failure-261012/ 2012-10-26T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-paranta-biosciences-sign-biologics-manufacturing-agreement-261012/ 2012-10-26T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-to-develop-oncomed-anti-cancer-therapeutics-261012/ 2012-10-26T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/amarantus-announces-positive-behavioural-efficacy-data-for-manf-in-rat-models-261012/ 2012-10-26T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/united-therapeutics-oral-formulation-of-remodulin-receives-crl-from-fda-261012/ 2012-10-26T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-net-sales-down-by-4-in-q3-2012-291012/ 2012-10-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-introduces-generic-version-of-actos-291012/ 2012-10-28T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/leo-pharma-taclonex-wins-fda-approval-for-body-plaque-psoriasis-291012/ 2012-10-29T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-revamps-microbial-xs-technology-ecoli-platform-291012/ 2012-10-29T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-clears-teva-synribo-injection-291012/ 2012-10-29T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/exist-software-labs-launches-web-based-emr-system-291012/ 2012-10-29T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/cirm-grants-diabetes-therapy-development-award-to-viacyte-291012/ 2012-10-29T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/cirm-grants-strategic-partnership-award-to-bluebird-bio-291012/ 2012-10-29T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/nestle-to-manufacture-ready-to-drink-medical-supplements-in-australia-291012/ 2012-10-29T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-initiates-patient-enrollment-in-anti-cancer-drug-trials-291012/ 2012-10-29T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/bizmatics-equips-prognocis-emr-with-dhin-interface-301012/ 2012-10-29T18:48:00+00:00 https://www.pharmaceutical-business-review.com/news/rehrig-pacific-intelleflex-to-develop-cold-chain-management-solutions-301012/ 2012-10-29T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/ctad-to-evaluate-alzheimers-disease-research-301012/ 2012-10-30T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-sells-rugby-otc-product-trademark-and-assets-to-harvard-drug-301012/ 2012-10-30T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/ocrc-completes-pk-unit-expansion-301012/ 2012-10-30T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/coldstream-laboratories-appoints-eric-smart-as-ceo-301012/ 2012-10-30T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-presents-pv-10-nonclinical-data-301012/ 2012-10-30T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/amarin-wins-new-us-patent-for-ultra-pure-omega-3-fatty-acid-product-301012/ 2012-10-30T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/mhra-grants-glp-re-certification-to-selcia-analytical-laboratory-301012/ 2012-10-30T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharma-introduces-leucovorin-calcium-for-injection-301012/ 2012-10-30T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/del-mar-guangxi-wuzhou-join-forces-to-develop-val-083-301012/ 2012-10-30T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aet-biotech-bioxpr-collaborate-for-biosimilar-version-of-tnf-inhibitor-311012/ 2012-10-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cenduit-sponsors-irt-conference-311012/ 2012-10-30T21:44:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-launches-quattrovac-subcutaneous-injection-in-japan-311012/ 2012-10-31T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-commences-falcon-breast-cancer-trial-311012/ 2012-10-31T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/chdi-extends-hd-research-collaboration-with-evotec-311012/ 2012-10-31T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-chooses-sparta-systems-trackwise-quality-management-software-311012/ 2012-10-31T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/complix-wins-19m-grant-to-advance-cpabs-development-311012/ 2012-10-31T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/tpp-sprint-bioscience-partner-to-develop-human-cancer-therapeutics-311012/ 2012-10-31T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/spermatech-selects-dotmatics-platform-311012/ 2012-10-31T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-launches-4-in-1-nutrition-shake-for-adults-311012/ 2012-10-31T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/stemcells-r-biomedical-in-human-ips-cell-line-development-agreement-311012/ 2012-10-31T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/patheon-to-buy-banner-pharmacaps-31012/ 2012-10-31T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/charles-river-to-acquire-major-stake-in-vital-river-311012/ 2012-10-31T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/new-penn-pharma-appoints-truppi-as-us-business-development-manager-011112/ 2012-10-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/catalyst-biomarin-sign-firdapse-licensing-deal-011112/ 2012-10-31T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-phase-2-hiv-trial-meets-primary-objective-011112/ 2012-11-01T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/cytovance-wins-fountain-allergy-drug-development-contract-011112/ 2012-11-01T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/finesse-solutions-moves-to-new-manufacturing-facility-in-us-011112/ 2012-11-01T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/sihuan-roxatidine-wins-production-approval-011112/ 2012-11-01T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-adcetris-wins-european-conditional-marketing-authorization-011112/ 2012-11-01T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmalink-patheon-sign-nefecon-manufacturing-deal-011112/ 2012-11-01T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/en-vivo-presents-evp-6124-phase-2b-clinical-trial-data-011112/ 2012-11-01T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-construct-new-biotechnology-facility-in-singapore-011112/ 2012-11-01T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/australian-state-launches-new-plan-for-biotechnology-industry-growth-011112/ 2012-11-01T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/safc-crystalgenomics-to-develop-apis-for-nsaid-011112/ 2012-11-01T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-begins-phase-1-trial-of-oms824-021112/ 2012-11-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-to-invest-140m-in-insulin-manufacturing-facility-expansion-021112/ 2012-11-01T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/portola-bristol-myers-pfizer-collaborate-to-investigate-anticoagulant-antidote-021112/ 2012-11-02T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-gsk-partner-for-phase-2-all-oral-hepatitis-c-study-021112/ 2012-11-02T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/icf-international-receives-cims-contractfrom-us-health-department-021112/ 2012-11-02T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cobalt-light-systems-introduces-rapid-to-identify-pharmaceutical-raw-materials-021112/ 2012-11-02T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/emerson-to-distribute-douglas-nutritional-supplements-for-athletes-021112/ 2012-11-02T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fluidigm-unveils-new-ifcs-for-production-genomics-021112/ 2012-11-02T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ensemble-join-forces-to-discover-macrocycle-drugs-021112/ 2012-11-02T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-yervoy-for-skin-cancer-021112/ 2012-11-02T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/advanced-cell-diagnostics-secures-12m-in-series-b-equity-financing-021112/ 2012-11-02T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/bocagreenmd-to-launch-new-line-of-prenatal-multivitamins-021112/ 2012-11-02T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-restarts-influenza-vaccine-distribution-in-canada-021112/ 2012-11-02T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-launches-new-high-speed-centrifuge-for-laboratory-use-011112/ 2012-11-02T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-purchases-medisapiens-genomics-data-visualization-solution-051112/ 2012-11-04T20:59:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-announces-positive-28-week-data-from-eculizumab-trial-051112/ 2012-11-05T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-q3-net-income-declines-051112/ 2012-11-05T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-drug-status-to-alphacore-fld-candidate-051112/ 2012-11-05T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/sweden-funds-new-anti-malaria-therapy-051112/ 2012-11-05T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/frutarom-botanical-raw-materials-technology-soon-to-begin-us-production-051112/ 2012-11-05T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-recommends-raxibacumab-for-inhalational-anthrax-051112/ 2012-11-05T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-phase-iii-adpkd-trial-meets-primary-endpoint-051112/ 2012-11-05T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/skuldtech-ab-science-discover-new-pancreatic-cancer-predictive-markers-051112/ 2012-11-05T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/poxel-imeglimin-phase-ii-study-demonstrates-positive-results-051112/ 2012-11-05T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ccs-to-license-cevec-pharma-protein-production-technology-051112/ 2012-11-05T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-wins-icheme-2012-outstanding-achievement-award-051112/ 2012-11-05T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-reports-wider-q3-net-loss-051112/ 2012-11-05T12:50:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-rad-labs-to-provide-blood-bank-reagents-to-premier-071112/ 2012-11-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pioneer-pharma-provides-additional-equity-fundingto-novabay-061112/ 2012-11-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-commence-patient-recruitment-in-phase-3-cvot-061112/ 2012-11-06T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-introduces-iron-deficiency-anaemia-drug-in-europe-061112/ 2012-11-06T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/igi-laboratories-to-launch-its-first-labeled-generic-products-061112/ 2012-11-06T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/bioniche-terminates-phase-iii-bladder-cancer-trial-061112/ 2012-11-06T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/cypher-genomics-to-use-biobase-genome-trax-for-variant-analysis-061112/ 2012-11-06T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/medicure-signs-deal-to-promote-aggrastat-in-puerto-rico-061112/ 2012-11-06T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cyclacel-wins-uk-grant-to-advance-cyc065-drug-for-leukemias-061112/ 2012-11-06T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/study-says-probiotic-lowers-cholesterol-061112/ 2012-11-06T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/pdl-biopharma-reports-increased-q3-net-income-061112/ 2012-11-06T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/loblaw-to-launch-island-abbey-honey-lozenges-across-canada-stores-061112/ 2012-11-06T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-gsk-amend-existing-isis-ttr-rx-drug-development-plan-061112/ 2012-11-06T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/kalvista-secures-38m-uk-grant-for-dme-oral-plasma-drug-development-061112/ 2012-11-06T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-unveils-new-epigenetic-cellular-detection-research-kits-061112/ 2012-11-06T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/curis-q3-net-loss-decreases-071112/ 2012-11-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/suppremol-to-present-sm101-clinical-data-071112/ 2012-11-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-rheumatoid-arthritis-therapy-wins-fda-approval-071112/ 2012-11-07T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-q3-net-loss-narrows-071112/ 2012-11-07T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/visc-to-license-aerie-controlled-release-eye-d-technology-071112/ 2012-11-07T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-ildong-sign-belviq-commercialization-deal-in-south-korea-071112/ 2012-11-07T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/careuk-acquires-harmoni/ 2012-11-07T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/marijuana-receives-cannabinoid-medicinals-global-marketing-rights-071112/ 2012-11-07T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-noa-to-new-silence-drug-delivery-methods-071112/ 2012-11-07T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/dabigatran-etexilate-found-superior-to-warfarin-in-study-071112/ 2012-11-07T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/limr-wins-bill-melinda-gates-foundation-grant-071112/ 2012-11-07T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/santarus-pharming-ruconest-phase-iii-study-meets-primary-endpoint-071112/ 2012-11-07T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-and-pfizer-amend-xiapex-collaboration-agreement-081112/ 2012-11-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cornerstone-to-acquire-us-marketing-rights-to-chiesi-bethkis-solution-091112/ 2012-11-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/greenphire-to-provide-clincard-technology-for-long-term-clinical-trial-081112/ 2012-11-07T20:27:00+00:00 https://www.pharmaceutical-business-review.com/news/media-cybernetics-launches-new-dab-analysis-app-for-image-pro-software-081112/ 2012-11-07T21:57:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-acetadote-formulation-wins-second-patent-notice-of-allowance-in-us-081112/ 2012-11-08T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-trastuzumab-emtansine-081112/ 2012-11-08T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/agere-pharma-expands-cgmp-spray-dry-manufacturing-capabilities-081112/ 2012-11-08T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-completes-scale-up-production-process-for-plx-cells-081112/ 2012-11-08T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-q3-net-loss-increases-081112/ 2012-11-08T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/discoverx-takes-over-drug-discovery-service-provider-081112/ 2012-11-08T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/sehta-launches-new-uk-healthcare-innovation-hub-081112/ 2012-11-08T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/keryx-biopharmaceuticals-q3-net-loss-narrows-081112/ 2012-11-08T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/doe-ingalls-obtains-distilled-spirits-plant-permit-081112/ 2012-11-08T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmainformatic-develops-new-database-pact-f-091112/ 2012-11-08T22:42:00+00:00 https://www.pharmaceutical-business-review.com/news/taurx-chooses-bioclinica-eclinical-and-imaging-solutions-091112/ 2012-11-08T22:49:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-pediatric-crohns-disease-therapy-wins-fda-fast-track-status-091112/ 2012-11-09T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-supports-neb-to-advance-enzyme-research-for-epigenetic-studies-091112/ 2012-11-09T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/particle-sciences-develops-new-ocular-formulation-using-proprietary-polymer-091112/ 2012-11-09T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-janssen-agree-to-settle-ortho-tri-cyclen-lo-patent-litigation-091112/ 2012-11-09T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/xenoport-gsk-terminate-collaboration-on-horizant-tablets-091112/ 2012-11-09T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/airgas-biologics-modular-to-provide-modular-research-suites-091112/ 2012-11-09T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-submits-iw-2143-ind-application-to-fda-091112/ 2012-11-09T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-to-provide-services-to-nongs-091112/ 2012-11-09T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-reports-q3-net-loss-091112/ 2012-11-09T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-chiromics-partner-to-discover-small-molecules-against-biological-targets-121112/ 2012-11-12T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/intellicell-completes-registration-of-new-york-cell-processing-facility-121112/ 2012-11-12T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-abraxane-achieves-significant-improvement-in-overall-survival-in-phase-iii-study-121112/ 2012-11-12T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/gns-join-forces-with-dana-farber-mount-sinai-to-build-myeloma-computer-models-121112/ 2012-11-12T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/grnenthal-amura-sign-new-research-deal-121112/ 2012-11-12T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/telik-q3-net-loss-narrows-121112/ 2012-11-12T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/safecode-drug-technologies-plans-to-develop-first-product-prototype-121112/ 2012-11-12T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-acz885-meets-primary-endpoints-in-phase-ii-trials-131112/ 2012-11-12T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/researchers-develop-new-statistical-method-for-cancer-diagnosis-131112/ 2012-11-12T23:25:00+00:00 https://www.pharmaceutical-business-review.com/news/sophiris-bio-q3-net-loss-widens-131112/ 2012-11-13T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/links-launches-tablet-crushing-system-to-fight-hospitals-infections-131112/ 2012-11-13T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/gp-pharm-pharmalink-in-busulipo-manufacturing-agreement-131112/ 2012-11-13T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/humanzyme-pacificgmp-join-forces-to-manufacture-human-proteins-131112/ 2012-11-13T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-review-to-glenveigh-digoxin-immune-fab-131112/ 2012-11-13T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/methylgene-names-charles-baum-as-new-ceo-131112/ 2012-11-13T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/alacris-gsk-sign-deal-to-apply-modcell-system-in-cancer-research-141112/ 2012-11-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-reports-increased-q3-net-loss-141112/ 2012-11-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-seeks-japanese-approval-for-cancer-pain-medication-141112/ 2012-11-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-hyperacute-pancreas-immunotherapy-wins-orphan-drug-status-in-europe-141112/ 2012-11-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-astrazeneca-to-launch-type-2-diabetes-drug-in-uk-161112/ 2012-11-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/liaison-healthcare-introduces-patient-document-repository-solution-191112/ 2012-11-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biotime-subsidiary-lifemap-launches-new-bioreagents-portal-for-stem-cell-researchers-201112/ 2012-11-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aptuit-gsk-extend-strategic-drug-development-deal-141112/ 2012-11-14T00:25:00+00:00 https://www.pharmaceutical-business-review.com/news/probiogen-introduces-set-of-engineered-cho-production-cell-lines-141112/ 2012-11-14T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-introduces-acetazolamide-injection-141112/ 2012-11-14T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-geno-nda-filing-for-mvg-2000-nitric-oxide-delivery-system-141112/ 2012-11-14T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-to-license-barofold-high-pressure-protein-refolding-technology-141112/ 2012-11-14T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-savara-pharma-inhaled-antibiotic-therapy-141112/ 2012-11-14T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-molecular-partners-enter-manufacturing-agreement-141112/ 2012-11-14T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/epicept-q3-net-loss-narrows-151112/ 2012-11-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/capsugel-plant-based-capsules-manufacturing-facility-wins-european-organic-certification-191112/ 2012-11-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sekisui-opts-emc-technologies-for-new-data-centre-infrastructure-151112/ 2012-11-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-inaugurates-manufacturing-facility-for-life-sciences-equipment-in-china-201112/ 2012-11-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-adamas-sign-deal-to-develop-alzheimers-dementia-medication-151112/ 2012-11-15T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/alfa-laval-to-supply-processing-line-for-malaysian-insulin-plant-151112/ 2012-11-15T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-to-acquire-us-based-generic-and-branded-pharmaceutical-products-providers-151112/ 2012-11-15T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/associates-of-cape-cod-invasive-fungal-infection-diagnostic-test-wins-fda-nod-151112/ 2012-11-15T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/smc-approves-use-of-ocular-nsaid-in-diabetic-cataract-patients-151112/ 2012-11-15T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/talon-therapeutics-reports-q3-net-income-151112/ 2012-11-15T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/certolizumab-pegol-reduces-signs-and-symptoms-of-axial-spondyloarthritis-study-151112/ 2012-11-15T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pacira-new-data-supports-exparel-usage-in-postsurgical-pain-management-151112/ 2012-11-15T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/innovent-biologics-on-course-to-expand-pipeline-161112/ 2012-11-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-begins-patent-challenge-over-opana-er-generic-version-161112/ 2012-11-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-q3-net-loss-widens-161112/ 2012-11-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lct-phase-i-parkinsons-disease-trials-win-ethical-approval-in-new-zealand-161112/ 2012-11-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/symbiosis-to-move-to-sdi-boston-incubator-office-161112/ 2012-11-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/promega-opens-new-biological-products-facility-in-china-161112/ 2012-11-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-pharmaceuticals-ships-phendimetrazine-tartrate-tablets-161112/ 2012-11-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lgc-genomics-opens-new-laboratory-in-hoddesdon-161112/ 2012-11-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-reports-positive-data-from-phase-3b-hiv-study-of-complera-161112/ 2012-11-16T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-haplogen-join-forces-to-develop-anti-viral-compounds-160912/ 2012-11-16T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-therapeutics-reports-q3-net-loss-161112/ 2012-11-16T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/safc-add-new-raw-materials-to-pharmagrade-products-portfolio-161112/ 2012-11-16T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-to-manufacture-bulk-substance-for-thrombogenics-eye-medication-161112/ 2012-11-16T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/walmart-announces-availability-of-ecoslide-rx-prescription-pharmaceutical-package-161112/ 2012-11-16T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/tg-therapeutics-ildong-sign-licensing-deal-for-ublituximab-development-161112/ 2012-11-16T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/ans-performance-unveils-three-new-nutrition-supplements-161112/ 2012-11-16T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-declares-resolution-of-issues-concerning-snbl-usa-161112/ 2012-11-16T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-biocon-sign-option-agreement-for-insulin-drug-191112/ 2012-11-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/therapeuticsmd-selects-stayinfront-mobile-crm-edgerx-solutions-231112/ 2012-11-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-to-use-tessella-and-berry-consultants-adaptive-trial-design-solution-191112/ 2012-11-18T21:31:00+00:00 https://www.pharmaceutical-business-review.com/news/northrop-wins-30m-bisc-from-nih-191112/ 2012-11-19T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phase-3-pregabalin-study-fails-to-meet-primary-endpoint-191112/ 2012-11-19T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/epharmasolutions-unveils-patientlive-application-191112/ 2012-11-19T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-bexsero-wins-positive-chmp-opinion-from-ema-191112/ 2012-11-19T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/nhs-researchers-develop-new-test-to-diagnose-premature-birth-191112/ 2012-11-19T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-orexo-zubsolv-new-drug-application-191112/ 2012-11-19T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/exjade-receives-positive-opinion-from-ema-191112/ 2012-11-19T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/gvk-launches-isotope-labelling-unit-in-india-191112/ 2012-11-19T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-to-present-t-cells-clinical-trial-results-191112/ 2012-11-19T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/diffusion-completes-trans-sodium-crocetinate-phase-i-trial-201112/ 2012-11-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mesoblast-reaches-agreement-with-fda-for-supply-of-mesenchymal-precursor-cells-211112/ 2012-11-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biostar-pharmaceuticals-reports-net-loss-in-q3-211112/ 2012-11-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aptar-pharma-names-jean-marc-pardonge-as-prescription-division-new-president-211112/ 2012-11-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/clontech-chooses-snapgene-software-201112/ 2012-11-19T20:11:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-thrombocytopenia-medication-wins-fda-approval-201112/ 2012-11-20T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-seeks-fda-approval-for-tarceva-201112/ 2012-11-20T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cfft-pfizer-expand-cystic-fibrosis-drug-discovery-alliance-201112/ 2012-11-20T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/rising-pharmaceuticals-to-launch-generic-version-of-gris-pegr-201112/ 2012-11-20T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phase-3-fibromyalgia-study-of-pregabalin-meets-primary-endpoint-201112/ 2012-11-20T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/hebron-introduces-natural-ready-to-drink-probiotic-products-201112/ 2012-11-20T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/bavarian-nordic-receives-mva-bn-vaccine-development-fund-201112/ 2012-11-20T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-shoppe-sells-instaflex-joint-supportthrough-online-201112/ 2012-11-20T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/wood-creek-capital-validus-acquire-npc-products-rights-in-us-211112/ 2012-11-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/proteonomix-commences-umk-121-study-with-patient-screening-211112/ 2012-11-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-clears-bms-pfizer-oral-anticoagulant-211112/ 2012-11-20T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/affymetrix-cpgr-sign-research-deal-in-south-africa-211112/ 2012-11-20T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-awards-fast-track-status-to-acquired-hemophilia-a-drug-candidate-211112/ 2012-11-21T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-introduces-grass-pollen-allergy-medication-in-canada-211112/ 2012-11-21T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/pacria-publishes-exparel-improve-study-results-211112/ 2012-11-21T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/cml-healthcare-to-distribute-mitomics-prostate-cancer-test-in-canada-211112/ 2012-11-21T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/sihuan-signs-agreement-to-develop-neurovive-cardio-cerebral-vascular-drugs-in-china-211112/ 2012-11-21T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/kiadis-pharma-raises-fund-for-phase-ii-study-of-atir-211112/ 2012-11-21T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/prospec-lifemap-sciences-enter-into-distribution-agreement-211112/ 2012-11-21T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-algeta-sign-research-collaboration-for-tumour-targeting-therapeutics-evaluation-211112/ 2012-11-21T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/basilea-begins-bal30072-pharmacokinetic-phase-1-study-231112/ 2012-11-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/atox-reports-positive-data-from-ab103-study-in-necrotizing-soft-tissue-infections-221112/ 2012-11-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-multiple-sclerosis-medication-wins-approval-in-australia-221112/ 2012-11-22T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/oxigene-acute-myelogenous-leukemia-candidate-obtains-fda-orphan-drug-status-221112/ 2012-11-22T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-perrigo-to-jointly-develop-topical-generic-drug-221112/ 2012-11-22T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/systech-secures-75m-finance-for-software-products-expansion-221112/ 2012-11-22T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/planisware-launches-pre-packaged-project-portfolio-management-solution-221112/ 2012-11-22T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/rlc-completes-german-pharmacenter-expansion-21112/ 2012-11-22T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-releases-fenofibrate-tablets-in-us-221112/ 2012-11-22T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/amorfix-provides-ep-ad-assay-for-alzheimers-drug-development-221112/ 2012-11-22T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-childrens-shire-enter-pediatric-disease-research-collaboration-221112/ 2012-11-22T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-life-science-unveils-compozr-transporter-knockout-human-cell-lines-in-assay-ready-format-221112/ 2012-11-22T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-offers-to-acquire-pronova-221112/ 2012-11-22T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/arkivum-releases-new-digital-data-archiving-service-231112/ 2012-11-22T21:53:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-cell-culture-influenza-virus-vaccine-wins-fda-nod-231112/ 2012-11-22T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/cardio3-to-commence-phase-iii-heart-failure-trial-of-c3bs-cqr-1-in-belgium-231112/ 2012-11-23T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-wins-us-patent-for-oncology-based-compounds-231112/ 2012-11-23T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/energnaturals-releases-three-new-health-supplements-231112/ 2012-11-23T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/exemed-pharmaceuticals-to-buy-ucb-indian-production-facility-231112/ 2012-11-23T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/erytech-orphan-europe-sign-graspa-licensing-deal-in-europe-231112/ 2012-11-23T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-pharma-names-arvind-vasudeva-as-formulations-division-ceo-231112/ 2012-11-23T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-to-build-nutrition-manufacturing-plant-in-china-231112/ 2012-11-23T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/mentor-capital-nanovega-sign-nanotechnology-cancer-loi-231112/ 2012-11-23T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/reckitt-benckiser-to-acquire-schiff-nutrition-231112/ 2012-11-23T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/mplexus-to-introduce-image-sharing-and-retrieval-software-291112/ 2012-11-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/unfors-introduces-new-cloud-based-solution-to-lower-patient-radiation-dose-261112/ 2012-11-25T21:58:00+00:00 https://www.pharmaceutical-business-review.com/news/ais-unveils-touch-panel-computers-for-pharma-industry-261112/ 2012-11-25T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/mrna-vaccines-protect-against-viral-infections-in-study-261112/ 2012-11-26T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/cipla-names-new-ceo-26112/ 2012-11-26T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-recalls-atorvastatin-from-us-market-261112/ 2012-11-26T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-laboratories-launches-anti-acne-drug-in-us-261112/ 2012-11-26T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/aspireo-somatoprim-wins-positive-opinion-from-ema-committee-for-acromegaly-261112/ 2012-11-26T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmexcil-recommends1d-barcodes-on-pharma-packaging-261112/ 2012-11-26T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/bioazure-exhibits-repligens-bioprocessing-products-261112/ 2012-11-26T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/human-biostar-revises-stem-cell-laboratory-261112/ 2012-11-26T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-identifies-new-class-of-antibiotics-targeting-mrsa-strains-261112/ 2012-11-26T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pharming-earns-10m-milestone-payment-from-santarus-261112/ 2012-11-26T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/understanding-cell-biological-processes-helps-to-discover-new-medical-treatments-261112/ 2012-11-26T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-plans-to-raise-stake-in-indian-consumer-healthcare-subsidiary-271112/ 2012-11-27T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/schott-to-expand-russian-pharmaceutical-packaging-plant-271112/ 2012-11-27T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/nbty-buys-nutritional-bars-provider-in-us-271112/ 2012-11-27T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/sarepta-signs-research-deal-to-develop-duchenne-muscular-dystrophy-therapeutic-271112/ 2012-11-27T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/viridian-nutrition-to-recall-black-cohosh-root-capsules-271112/ 2012-11-27T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/xtl-biopharmaceuticals-buys-proteologics-shares-271112/ 2012-11-27T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/selcia-unveils-new-ppiases-screening-service-271112/ 2012-11-27T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/itl-upgrades-israel-cell-manufacturing-facility-271112/ 2012-11-27T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/rising-pharmaceuticals-unveils-generic-version-of-cleocin-pediatric-271112/ 2012-11-27T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/accera-begins-alzheimers-disease-study-with-ac-1204-271112/ 2012-11-27T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-bayer-aflibercept-solution-for-injection-for-wet-amd-271112/ 2012-11-27T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/stormont-vail-to-integrate-hyland-onbase-with-epic-emr-281112/ 2012-11-27T20:30:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-national-taiwan-university-hospital-to-jointly-support-research-in-taiwan-281112/ 2012-11-28T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/vtu-technology-minapharm-sign-rhsa-licensing-deal-281112/ 2012-11-28T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lanthio-pharma-morphosys-join-forces-to-develop-new-therapeutic-peptides281112/ 2012-11-28T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/lorus-collaborates-with-cancer-research-uk-to-advance-solid-tumor-agent-281112/ 2012-11-28T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/emh-healthcare-uses-amcoms-ctrm-solution-281112/ 2012-11-28T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/skinvisible-receives-us-patent-for-stabilizing-retinoids-281112/ 2012-11-28T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/lifemap-sciences-introduces-database-platform-of-human-cellular-life-281112/ 2012-11-28T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrums-new-fusilev-manufacturing-facility-wins-fda-nod-281112/ 2012-11-28T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-clears-avaxia-ind-for-ulcerative-colitis-therapy-281112/ 2012-11-28T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/shanghai-jingfeng-carbylan-in-hydros-ta-technology-license-agreement-281112/ 2012-11-28T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fate-therapeutics-commences-phase-2-prohema-study-281112/ 2012-11-28T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ocusoft-announces-online-availability-of-zytaze-nutritional-supplement-291112/ 2012-11-28T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bdi-recalls-isovue-pfs-injector-syringes-281112/ 2012-11-28T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-announces-phase-3-positron-study-results-281112/ 2012-11-28T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-pharma-industry-eyes-exports-for-business-growth-291112/ 2012-11-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/selecta-sanofi-partner-to-develop-new-immunotherapies-against-allergies-291112/ 2012-11-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kesa-partners-agrees-to-buy-of-nextpharma-us-affiliate-bioserv-031212/ 2012-11-28T22:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-takes-over-nextwave-pharmaceuticals-291112/ 2012-11-28T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/beactica-janssen-extend-research-services-deal-291112/ 2012-11-28T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-probiodrug-partner-to-advance-drug-development-operations-291112/ 2012-11-29T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-aveo-astellas-tivozanib-nda-for-renal-cell-carcinoma-291112/ 2012-11-29T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/corerx-viropro-sign-reciprocal-referral-deal-to-advance-new-medicines-291112/ 2012-11-29T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/curis-licenses-gdc-0917-from-genentech-291112/ 2012-11-29T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/tty-biopharm-opens-new-anti-cancer-drug-factory-in-china-291112/ 2012-11-29T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/acg-to-construct-new-manufacturing-plant-in-india-291112/ 2012-11-29T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/chi-med-nestle-health-science-to-establish-nutrition-science-partners-291112/ 2012-11-29T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/meridian-health-physicians-to-access-practice-fusion-free-emr-301112/ 2012-11-29T19:46:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-opens-new-facility-to-enhance-patient-service-operations-at-rtp-301112/ 2012-11-30T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/antibodypedia-catalogues-half-million-antibodies-301112/ 2012-11-30T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-generic-overactive-bladder-medication-301112/ 2012-11-30T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/actinium-philogen-starts-pre-clinical-development-of-alpha-therapy-based-cancer-drug-301112/ 2012-11-30T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/capsugel-opens-new-quality-control-laboratory-in-us-301112/ 2012-11-30T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-seeks-orphan-drug-status-for-non-opioid-analgesic-candidate-301112/ 2012-11-30T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/dna20-newcastle-university-to-develop-bacillus-subtillis-expression-system-301112/ 2012-11-30T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/steripack-equips-us-facility-with-qad-applications-301112/ 2012-11-30T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-integrates-services-to-support-customer-demand-041212/ 2012-12-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/insite-vision-completes-patient-enrollment-for-bromsite-clinical-study-031212/ 2012-12-03T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/celestial-seasonings-launches-new-sleep-supplement-031212/ 2012-12-03T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/solvias-hovione-join-forces-for-improved-drug-delivery-031212/ 2012-12-03T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-leiden-university-to-support-pharmaceutical-research-031212/ 2012-12-03T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-launches-nafcillin-for-injection-031212/ 2012-12-03T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/emmaus-completes-recruitment-for-phase-iii-sickle-cell-anemia-therapy-trial-031212/ 2012-12-03T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/nestle-buys-pfizers-nutrition-business-031112/ 2012-12-03T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/northlake-mundipharma-collaborate-to-develop-alkylating-agents-031212/ 2012-12-03T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/theravectys-to-initiate-phase-iii-trial-of-anti-hiv-therapeutic-vaccine-031212/ 2012-12-03T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/cambrex-appoints-yanai-as-board-of-directors-vice-chairman-031212/ 2012-12-03T09:00:00+00:00 https://www.pharmaceutical-business-review.com/news/tot-biopharm-inaugurates-new-production-facility-in-china-041212/ 2012-12-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/io-informatics-extends-sentinent-to-precision-medicine-applications-041212/ 2012-12-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/showa-denko-joins-forces-with-biasep-to-enter-purification-resin-market-101212/ 2012-12-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/worldwide-clinical-trials-uses-transperfect-platform-for-tmf-documentation-management-041212/ 2012-12-03T22:12:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-astellas-commence-tivozanib-breast-cancer-trial-0412121/ 2012-12-04T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-ipsen-extend-dysport-collaboration-041212/ 2012-12-04T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/bioasis-ucb-in-cns-therapeutic-delivery-technology-research-deal-041212/ 2012-12-04T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-begins-erwinaze-trial-in-acute-lymphoblastic-leukemia-patients-041212/ 2012-12-04T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/genewiz-adds-cancer-panels-to-next-generation-sequencing-service-portfolio-041212/ 2012-12-04T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/altravax-receives-nih-grants-to-support-hiv-1-vaccine-research-041212/ 2012-12-04T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-appoints-new-chief-executive-officer-041212/ 2012-12-04T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/mundipharma-to-present-bendamustine-data-at-ash-meeting-041212/ 2012-12-04T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/cromsource-names-christian-milla-as-medical-division-head-041212/ 2012-12-04T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-wins-approval-for-expanded-indication-of-menactra-in-canada-041212/ 2012-12-04T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/vical-signs-vaxfectin-adjuvant-licensing-deal-with-cyvax-051212/ 2012-12-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmapros-to-supply-study-management-technology-for-clinical-development-program-051212/ 2012-12-04T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/versapharm-deploys-1-edi-sources-electronic-data-interchange-solution-051212/ 2012-12-04T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/parabon-wins-nsf-joint-grant-to-co-develop-prostate-cancer-therapeutic-with-janssen-051212/ 2012-12-05T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/biostar-signs-drug-manufacturing-contract-with-xijing-military-hospital-051212/ 2012-12-05T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-teva-sign-neuvax-commercialization-contract-in-israel-051212/ 2012-12-05T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/essex-woodlands-opens-healthcare-investment-office-in-china-051212/ 2012-12-05T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/ocean-global-launches-new-over-the-counter-solution-to-treat-vertigo-05112/ 2012-12-05T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/walgreens-acquires-uch-pharmaceutical-services-051212/ 2012-12-05T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-receives-us-patent-for-narcolepsy-treatment-051212/ 2012-12-05T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/epigenomics-epi-procolon-test-found-to-be-non-inferior-to-fecal-immunochemical-testing-051212/ 2012-12-05T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-wins-us-patent-protecting-unlocked-nucleobase-analog-chemistry-051212/ 2012-12-05T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fhcmb-receives-nih-anthrax-vaccines-development-contract-051212/ 2012-12-05T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-launches-rayos-in-us-051212/ 2012-12-05T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-new-nova-xaluprine-oral-formulation-061212/ 2012-12-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/plexxikon-chooses-certaras-d360-software-061212/ 2012-12-05T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-generic-hypertension-medication-061212/ 2012-12-06T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-signs-manufacturing-deal-with-apexigen-061212/ 2012-12-06T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/santen-deploys-sparta-systems-trackwise-solution-061212/ 2012-12-06T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ssb-unveils-sartoguard-nf-prefilter-series-061212/ 2012-12-06T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-updates-faslodex-injection-label-in-us-061212/ 2012-12-06T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-begins-td-9855-phase-2-study-in-fibromyalgia-patients-061212/ 2012-12-06T01:45:00+00:00